ADC Therapeutics and Adagene announce discovery collaboration agreement

Drug Discovery |  News | 0 Comment | 25 Apr, 2019

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), and Adagene Inc., an antibody engine...Read more

Roche launches Emicizumab in India

Drug Discovery |  News | 0 Comment | 21 Apr, 2019

Roche has declared  that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with factor VIII inhibitors. It is indicated as a prophylactic(preventive) treatment to ...Read more

Japan grants Sakigake designation to Eisai’s novel FGFR

Drug Discovery |  News | 0 Comment | 08 Apr, 2019

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The company has announced that its in-house discovered fibroblast growth fa...Read more

Takeda takes step towards EU Entyvio extension

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a subcutaneous (SC) formulatio...Read more

Standigm raises $11.5M in Series B Round

Drug Discovery |  News | 0 Comment | 02 Apr, 2019

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has raised $11.5 million in a Series B funding round led by Mirae Asset Ve...Read more

Takeda, StrideBio to advance novel gene therapies for neuro diseases

Drug Discovery |  News | 0 Comment | 01 Apr, 2019

StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the signing of a collaboration and license agreement with Takeda Pharmaceu...Read more

HitGen, Almirall to identify novel drug targets

Drug Discovery |  News | 0 Comment | 26 Mar, 2019

HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more

BioInvent developes Anti-TNFR2 programme for cancer treatment

Drug Discovery |  News | 0 Comment | 21 Mar, 2019

BioInvent International AB, focused on the discovery and development of novel and first-in-class immuno-regulatory antibody-based medicines generated by its proprietary platforms, disclosed...Read more

EC approves Roche’s MabThera for a rare autoimmune disease

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Roche announced that the European Commission has approved MabThera® (rituximab) for the treatment of adults with moderate to severe pemphigus vulgaris (PV), a rare condition characteris...Read more

Ono Pharma, twoXAR announce drug discovery research collaboration

Drug Discovery |  News | 0 Comment | 19 Mar, 2019

Ono Pharmaceutical Co., Ltd., a Japanese pharmaceutical research and development company, and twoXAR, Inc., a US based artificial intelligence (AI)-driven biopharmaceutical company, have an...Read more

Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma

Drug Discovery |  News | 0 Comment | 14 Mar, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) se...Read more

FDA approves new nasal spray for treatment-resistant depression

Drug Discovery |  News | 0 Comment | 06 Mar, 2019

The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried ot...Read more

Glenmark announces presentation of New Subtype Analysis of GBR 830

Drug Discovery |  News | 0 Comment | 04 Mar, 2019

Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-concept study of GBR 830 at the American Academy of Dermatology (AAD) An...Read more

USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug

Drug Discovery |  News | 0 Comment | 12 Feb, 2019

Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for BAVEN...Read more

Teva announces US launch of Vigabatrin

Drug Discovery |  News | 0 Comment | 08 Feb, 2019

Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril® (viga...Read more

Perrigo to launch its AB rated generic Zovirax cream

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing Zovirax® Cream,...Read more

BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug

Drug Discovery |  News | 0 Comment | 07 Feb, 2019

BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to it...Read more

Reaction Biology Corporation buys ProQinase GmbH

Drug Discovery |  News | 1 Comment | 05 Feb, 2019

Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange transaction through which RBC has acquired all the shares of ProQinase G...Read more